HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Combined Oxidative Phosphorylation Deficiency 4
Also Known As:
COXPD4
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Disease Context: Research Results
Nutritional and Metabolic Diseases: 15
Metabolic Diseases: 10142
Mitochondrial Diseases: 21919
Combined Oxidative Phosphorylation Deficiency 4: 1
Inborn Errors Metabolism: 1162
Combined Oxidative Phosphorylation Deficiency 4: 1
Acid-Base Imbalance: 249
Acidosis: 17197
Lactic Acidosis: 3887
Combined Oxidative Phosphorylation Deficiency 4: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
Inborn Genetic Diseases: 11939
Inborn Errors Metabolism: 1162
Combined Oxidative Phosphorylation Deficiency 4: 1
Experts
1.
Lei, Yu
: 1 article (03/2013)
2.
Ting, Jenny P Y
: 1 article (03/2013)
3.
Wen, Haitao
: 1 article (03/2013)
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Combined Oxidative Phosphorylation Deficiency 4:
1.
Mitochondrial Proteins (Mitochondrial Protein)
IBA
03/01/2013 - "
This effect is through its interaction with another mitochondrial protein TUFM (Tu translation elongation factor, mitochondrial, also known as EF-TuMT, COXPD4, and P43).
"
2.
Peptide Elongation Factors (Elongation Factor)
IBA
03/01/2013 - "
This effect is through its interaction with another mitochondrial protein TUFM (Tu translation elongation factor, mitochondrial, also known as EF-TuMT, COXPD4, and P43).
"